Bharat Biotech pursues COVID-19 vaccine approval in over 40 countries

"We have submitted our documentation in Brazil and other countries and await their approval. We plan to export several million doses to Brazil," the company said in an emailed statement. "Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes," it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news